Open access policies of journals with high impact factors that offer immediate open access with the CC BY licence (n=21)
Publisher | Organisation status | Journals included (n=21) | Open access variants available* | Funding requirements for obtaining open access with a CC BY licence | ||
Embargo period† | Creative commons licence | Version of article available | ||||
American Association for the Advancement of Science | Non-profit society | Science; Sci Transl Med | None | CC BY | VoR | The american association for the advancement of science ‘will allow authors funded by the Bill & Melinda Gates Foundation to publish their research with a CC BY licence’‡ |
None | None | Accepted | ||||
6 months | None | Accepted | ||||
12 months | None | VoR | ||||
American Society of Clinical Oncology | Non-profit society | J Clin Oncol | None | CC BY CC BY-NC-ND | VoR | Creative commons licences available only if funders are ‘academical institutions, not-for-profit organisations, philanthropical foundations or government agencies’ |
6 months | None | VoR | ||||
12 months | None | VoR | ||||
BMJ Publishing Group | Non-profit society | BMJ | None | CC BY CC BY-NC | VoR | CC BY licence available for authors ‘where the funder requires it’ |
Cell Press | Commercial | Cancer Cell; Cell; Cell Metab; Cell Stem Cell; Immunity | None | CC BY CC BY-NC-ND | VoR | Creative commons licences ‘available only to authors covered by a funding body agreement’ (these non-commercial funding bodies are listed on the journal websites) |
12 months | None | Accepted | ||||
Elsevier | Commercial | Eur Urol; Gastroenterology; J Am Coll Cardiol; Lancet; Lancet Diabetes Endocrinol; Lancet Infect Dis; Lancet Oncol; Lancet Neurol; Lancet Respir Med | None | CC BY CC BY-NC-ND | VoR Accepted§/VoR | Creative commons licences are available to authors funded by specific funding bodies (these non-commercial funding bodies are listed on the journal websites) Elsevier has established agreements and developed policies to allow authors who publish in Elsevier journals to comply with manuscript archiving requirements of various funding bodies (these non-commercial funding bodies are listed on the journal websites) |
6 months | None | VoR | ||||
European Society of Cardiology | Non-profit society | Eur Heart J | None | CC BY CC BY-NC CC BY-NC-ND | VoR | ‘RCUK/Wellcome Trust-funded authors…can use the CC BY licence for their articles’ |
None | None | Accepted | ||||
12 months | None | Accepted | ||||
Lippincott Williams & Wilkins | Commercial | Circulation | None | CC BY CC BY-NC CC BY-NC-ND | VoR | “Note that authors funded by RCUK or the Wellcome Trust may choose the CC BY licence if they agree to pay the article processing charge and commercial reuse of the article is not a factor’ |
6–12 months | None | Accepted | ||||
Wiley-Blackwell | Commercial | CA Cancer J Clin | None | CC BY CC BY-NC CC BY-NC-ND | VoR | ‘All RCUK and Wellcome Trust-funded authors will be directed to the CC BY licence’ |
12–24 months | None | Accepted |
CC BY, Creative Commons Attribution; NC, Non-Commercial; ND, No Derivatives; RCUK, Research Councils UK; VoR, version of record.
*Available under the terms specified on the journal website.
†None = immediate open access; >0 months = delayed open access.
‡The American Association for the Advancement of Science’s pilot open access partnership with the Gates Foundation concluded on 30 June 2018.39
§Accepted manuscripts can be self-archived and are required to attach a CC BY-NC-ND licence.25